Hematologic neoplasias and acromegaly

Pituitary

Volumn 14, Issue 4, 2011, Pages 377-381

  Barbosa, Flavia Regina P ^a   Vieira Neto, Leonardo ^a   Lima, Giovanna Aparecida B ^a   Wildemberg, Luiz Eduardo ^a   Portugal, Rodrigo ^a   Gadelha, Monica R ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Acromegaly; Growth hormone; Insulin like growth factor type I; Multiple myeloma; Waldenstrom's macroglobulinemia

Indexed keywords

CALCIUM; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; GROWTH HORMONE; OCTREOTIDE; PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UREA; VINCRISTINE;

ABDOMINAL PAIN; ACROMEGALY; ADENOMA; ADULT; ARTICLE; B LYMPHOCYTE ACTIVATION; BONE MARROW BIOPSY; BONE PAIN; CANCER RISK; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CONTROL; DISEASE DURATION; DIZZINESS; DRUG DOSE INCREASE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FATIGUE; FEMALE; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HYPERTENSION; HYPOPHYSIS ADENOMA; MACROADENOMA; MULTIPLE MYELOMA; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SELLA TURCICA TUMOR; SPLENOMEGALY; TRANSSPHENOIDAL HYPOPHYSECTOMY; VOMITING; WALDENSTROEM MACROGLOBULINEMIA; WEAKNESS;

ACROMEGALY; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MIDDLE AGED; MULTIPLE MYELOMA; WALDENSTROM MACROGLOBULINEMIA;

EID: 80053910685     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-009-0176-0     Document Type: Article

References (48)

1. Longo DL, Anderson KC (2007) Plasma cell disorders. Principles of Internal Medicine. Harrison 16th edn. McGraw Hill, pp 656-662
2. I Kanazawa T Yamaguchi Y Yamane M Norio Y Kato T Sugimoto 2006 Acromegaly associated with monoclonal gammopathy of undertermined significance (MGUS) Endocr J 53 687 691 10.1507/endocrj.K05-173 16926522 10.1507/endocrj.K05-173 1:CAS:528:DC%2BD2sXksl2gsg%3D%3D (Pubitemid 44691023)
3. MS Linet SD Harlow JK McLaughlin 1987 A case-control study of multiple myeloma in whites: chronic antigenic stimulation, occupation, and drug use Cancer Res 47 2978 2981 3567914 1:STN:280:DyaL2s7oslWrtQ%3D%3D (Pubitemid 17113446)
4. FD Groves LB Travis SS Devesa LA Ries JF Fraumeni Jr 1998 Waldenström's macroglobulinemia: incidence patterns in the United States, 1988-1994 Cancer 82 1078 1081 10.1002/(SICI)1097-0142(19980315)82:6<1078:: AID-CNCR10>3.0.CO;2-3 9506352 10.1002/(SICI)1097-0142(19980315)82:6<1078:: AID-CNCR10>3.0.CO;2-3 1:STN:280:DyaK1c7msFWktw%3D%3D (Pubitemid 28136520)
5. RA Kyle TM Therneau SV Rajkumar DR Larson MF Plevak LJ Melton 2004 3rd Incidence of multiple myeloma in Olmsted County, Minnesota: trend over 6 decades Cancer 101 2667 2674 10.1002/cncr.20652 15481060 10.1002/cncr.20652 (Pubitemid 39532300)
6. DA Riedel LM Pottern 1992 The epidemiology of multiple myeloma Hematol Oncol Clin North Am 6 225 247 1582971 1:STN:280:DyaK383lvFCjtA%3D%3D
7. SM Orme RJQ Mcnally RA Cartwright PE Belchetz 1998 Mortality and cancer incidence in acromegaly: a retrospective cohort study J Clin Endocrinol Metab 83 2730 2734 10.1210/jc.83.8.2730 9709939 10.1210/jc.83.8.2730 1:CAS:528:DyaK1cXltlWms7k%3D (Pubitemid 28493768)
8. WJ Murphy H Rui DL Longo 1995 Effects of growth hormone and prolactin immune development and function Life Sci 57 1 14 10.1016/0024-3205(95)00237-Z 7596216 10.1016/0024-3205(95)00237-Z 1:CAS:528:DyaK2MXmtVClsbk%3D
9. P Georgii-Hemiming HJ Wiklund Ljunggren K Nilsson 1996 Insulin-like growth factor-I is a growth and survival factor in human multiple myeloma cell lines Blood 88 2250 2258 (Pubitemid 26307929)
10. E Hagg K Asplund J Holm 1988 Acromegaly and multiple myeloma Ann Intern Med 109 437 438 3408064 1:STN:280:DyaL1czgvVWgsg%3D%3D
11. A Tucci S Bonadona C Cattaneo M Ungari A Giustina R Guiseppe 2003 Transformation of a MGUS to Overt Multiple Myeloma: the possible role of a pituitary macroadenoma secreting high levels of insulin-like growth factor 1 Leuk Lymphoma 44 543 545 10.1080/1042819021000037895 12688330 10.1080/1042819021000037895 1:CAS:528:DC%2BD38Xptlymsbk%3D (Pubitemid 36113904)
12. S Melmed 1990 Acromegaly N Engl J Med 322 966 977 2179724 10.1056/NEJM199004053221405 1:STN:280:DyaK3c7ptVyjsw%3D%3D
13. L Alexander D Appleton R Hall WM Ross R Wilkinson 1980 Epidemiology of acromegaly in the Newcastle region Clin Endocrinol (Oxf) 12 71 79 10.1111/j.1365-2265.1980.tb03135.x 10.1111/j.1365-2265.1980.tb03135.x 1:STN:280:DyaL3c3gtVektw%3D%3D (Pubitemid 10174985)
14. B Bengtsson S Eden I Ernest A Oden B Sjogren 1988 Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984 Acta Med Scand 223 327 335 3369313 10.1111/j.0954-6820.1988.tb15881.x 1:STN:280:DyaL1c3itVSruw%3D%3D
15. AD Wright DM Hill C Lowy TR Fraser 1970 Mortality in acromegaly Q J Med 39 1 16 5427331 1:STN:280:DyaE3c3jtVOmtg%3D%3D
16. J Etxabe P Gaztambide P Latorre JA Vasquez 1993 Acromegaly: an epidemiological study J Endocrinol Invest 16 181 187 8514973 1:STN:280:DyaK3s3psVWgtA%3D%3D (Pubitemid 23137956)
17. S Melmed 2001 Acromegaly and cancer: not a problem? J Clin Endocrinol Metab 86 2929 2934 10.1210/jc.86.7.2929 11443145 10.1210/jc.86.7.2929 1:CAS:528:DC%2BD3MXlt1GjsrY%3D (Pubitemid 32673443)
18. JM Chan MJ Stampfer E Giovannucci PH Gann J Ma P Wilkinson CH Hennekens M Pollak 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study Science 279 563 566 10.1126/science.279.5350.563 9438850 10.1126/science.279.5350.563 1:CAS:528:DyaK1cXotVOqsg%3D%3D (Pubitemid 28067285)
19. ES Schernhammer JM Holly MN Pollak SE Hankinson 2005 Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk Cancer Epidemiol Biomarkers Prev 14 699 704 10.1158/1055-9965.EPI-04-0561 15767352 10.1158/1055-9965.EPI-04-0561 1:CAS:528:DC%2BD2MXit1Kgurw%3D (Pubitemid 40489217)
20. PJ Jenkins M Besser 2001 Acromegaly and cancer: a problem J Clin Endocrinol Metab 86 2935 2941 10.1210/jc.86.7.2935 11443146 10.1210/jc.86.7.2935 1:CAS:528:DC%2BD3MXlt1Gjsrc%3D (Pubitemid 32673444)
21. H Yu MR Spitz J Mistry J Gu WK Hong X Wu 1999 Plasma levels of insulin-like growth factor-1 and lung cancer risk: a case-control analysis J Natl Cancer Inst 91 151 156 10.1093/jnci/91.2.151 9923856 10.1093/jnci/91.2.151 1:STN:280:DyaK1M7itVOgsw%3D%3D (Pubitemid 29042692)
22. P Tita MR Ambrosio C Scollo A Carta P Gangemi M Bondanelli R Vigneri EC degli Uberti V Pezzino 2005 High prevalence of differentiated thyroid carcinoma in acromegaly Clin Endocrinol (Oxf) 63 161 167 10.1111/j.1365-2265.2005.02316.x 10.1111/j.1365-2265.2005.02316.x (Pubitemid 41097984)
23. H Yu T Rohan 2000 Role of insulin-like growth factor family in cancer development and progression J Natl Cancer Inst 92 1472 1489 10.1093/jnci/92.18. 1472 10995803 10.1093/jnci/92.18.1472 1:CAS:528:DC%2BD3cXntFKqsrw%3D
24. GAB Lima EMS Gomes RC Nunes L Vieira Neto APAV Sieiro EP Brabo MR Gadelha 2006 Osteosarcoma and acromegaly: a case report and review of the literature J Endocrinol Invest 29 1006 1011 17259799 1:STN:280:DC%2BD2s%2FlsFehsg%3D%3D (Pubitemid 46344236)
25. E Giovannucci 1999 Insulin-like growth factor-I and binding protein-3 and risk of cancer Horm Res 51 34 41 10.1159/000053160 10592442 10.1159/000053160 1:CAS:528:DyaK1MXnvVyhurs%3D
26. S Grinspoon D Clemmons B Swearingen, et al. 1995 Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly J Clin Endocrinol Metab 80 927 932 10.1210/jc.80.3.927 7533774 10.1210/jc.80.3.927 1:CAS:528:DyaK2MXktlOntbg%3D
27. A Juul K Main WF Blum, et al. 1994 The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients Clin Endocrinol (Oxf) 41 85 93 10.1111/j.1365-2265.1994.tb03788.x 10.1111/j.1365-2265.1994.tb03788.x 1:STN:280:DyaK2czis1eqtw%3D%3D (Pubitemid 24232532)
28. K Bohlke DW Cramer D Trichopoulos CS Mantzoros 1998 Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast Epidemiology 9 570 573 10.1097/00001648-199809000-00018 9730040 10.1097/00001648-199809000-00018 1:STN:280:DyaK1czpslOktQ%3D%3D (Pubitemid 28387961)
29. A Wolk CS Mantzoros S-O Andersson H Bergström LB Signorello P Lagiou H-O Adami D Trichopoulos 1998 Insulin-like growth factor 1 and prostate cancer risk: a population based, case control study J Natl Cancer Inst 90 911 915 10.1093/jnci/90.12.911 9637140 10.1093/jnci/90.12.911 1:CAS:528: DyaK1cXktFOqsLc%3D (Pubitemid 28304159)
30. P Aman G Lundin K Hall G Klein 1981 Insulin receptors on human lymphoid lines of B-cell origin Cell Immunol 65 307 314 10.1016/0008-8749(81)90076-9 10.1016/0008-8749(81)90076-9 1:CAS:528:DyaL38XpvVWnug%3D%3D
31. TG Baier EW Jenne W Blum D Schonberg KKP Hartmann 1992 Influence of antibodies against IGF-I, insulin or their receptors on proliferation of human acute lymphoblastic leukemia cell lines Leuk Res 16 807 814 10.1016/0145- 2126(92)90160-9 1326686 10.1016/0145-2126(92)90160-9 1:CAS:528: DyaK3sXpvFWrsg%3D%3D
32. SC van Buul-Offers R Kooijman 1998 The role of growth hormone and insulin-like growth factors in the immune system Cell Mol Life Sci 54 1083 1094 10.1007/s000180050237 9817987 10.1007/s000180050237 (Pubitemid 28491017)
33. R Clark J Strasser S Mc Cabe K Robbins P Jardieu 1993 Insulin-like growth factor-I stimulation of lymphopoiesis J Clin Invest 92 540 548 10.1172/JCI116621 8349796 10.1172/JCI116621 1:CAS:528:DyaK2cXhsVGj (Pubitemid 23262369)
34. KS Landreth R Narayanan K Dorshkind 1992 Insulin-like growth factor-I regulates pro-B cell differentiation Blood 80 1207 1212 1515639 1:CAS:528:DyaK38XlvVGmtL4%3D
35. DM Hilbert M Kopf BA Mock G Kohler S Rudikoff 1995 Interleukin 6 is essential for in vivo development of B lineage neoplasms J Exp Med 182 243 248 10.1084/jem.182.1.243 7790819 10.1084/jem.182.1.243 1:CAS:528:DyaK2MXmsVCksbw%3D
36. G Lattanzio C Libert M Aquillina M Cappelletti G Ciliberto P Musiani V Poli 1997 Defective development of pristine-oil-induced plasmocytomas in interleukin-6-deficient BALB/c mice Am J Pathol 151 689 696 9284817 1:CAS:528:DyaK2sXmt1Sqtbg%3D (Pubitemid 27385600)
37. DM Hilbert TS Migone M Kopf WJ Leonard S Rudikoff 1996 Distinct tumorigenic potential of abi and raf in B cell neoplasia:abl activates the IL-6 signaling pathway Immunity 5 81 89 10.1016/S1074-7613(00)80312-X 8758897 10.1016/S1074-7613(00)80312-X 1:CAS:528:DyaK28Xks1Omtbc%3D (Pubitemid 26254787)
38. BA Barut LI Zon MK Cochran SR Paul D Chauhan A Mohrbacher J Fingeroth KC Anderson 1992 Role of interleukin 6 in the growth of myeloma-derived cell lines Leuk Res 16 951 959 10.1016/0145-2126(92)90073-G 1405708 10.1016/0145-2126(92) 90073-G 1:CAS:528:DyaK3sXnvFWqtw%3D%3D
39. B Klein XG Zhang ZY Lu R Batallie 1995 Interleukin-6 in human multiple myeloma Blood 85 863 872 7849308 1:CAS:528:DyaK2MXjs1Ojt7o%3D
40. JP Gaillard J Liautard B Klein J Brochier 1997 Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines Eur J Immunol 27 3332 3340 10.1002/eji.1830271232 9464821 10.1002/eji.1830271232 1:CAS:528: DyaK1cXisF2lsw%3D%3D (Pubitemid 28018030)
41. L Bergui M Schena G Gaidano M Riva F Caligaris-Cappio 1989 Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma J Exp Med 170 613 618 10.1084/jem.170.2.613 2787832 10.1084/jem.170.2.613 1:CAS:528:DyaL1MXltlahsLc%3D (Pubitemid 19204289)
42. DM Nachabaur M Herold A Maneschg H Huber 1991 Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters Ann Hematol 62 54 58 10.1007/BF01714900 10.1007/BF01714900
43. J Thaler F Fechner M Herold H Huber 1994 Interleukin-6 in multiple myeloma: correlation with disease activity and Ki-67 proliferation index Leuk Lymphoma 12 265 271 10.3109/10428199409059598 8167557 10.3109/10428199409059598 1:STN:280:DyaK2c3itV2mtg%3D%3D (Pubitemid 24077176)
44. R Bataille B Barlogie ZY Lu JF Rossi T Lavabre-Bertrand T Beck J Wijdenes J Brochier B Klein 1994 Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma Blood 86 685 691
45. NL Ge S Rudikoff 2000 Insulin-like growth factor I is a dual effector of multiple myeloma cell growth Blood 96 2856 2861 11023522 1:CAS:528: DC%2BD3cXnt12gt78%3D
46. V Popovic S Damjanovic D Micic M Nesovic M Djurovic M Petakov S Obradovic S Zoric M Simic Z Penezic J Marinkovic The Pituitary Study Group 1998 Increased incidence of neoplasia in patients with pituitary adenomas Clin Endocrinol (Oxf) 49 441 445 10.1046/j.1365-2265.1998.00536.x 10.1046/j.1365-2265.1998. 00536.x 1:STN:280:DyaK1M%2FptlKhsg%3D%3D (Pubitemid 28475335)
47. RH Alves M Vaisman RR Brasil MR Gadelha 1998 Acromegaly and non-Hodgkin's lymphoma Endocr Pract 4 279 281 15251725 1:STN:280:DC%2BD2czkvVCjtw%3D%3D
48. O Vancollie E Delgrange JE Donckier 1999 Acromegaly and Waldenstrom's macroglobulinemia Acta Clin Belg 54 6 357 10686709 1:STN:280: DC%2BD3c7ltFehtw%3D%3D